Today: 29 April 2026
PotlatchDeltic stock price today: Why PCH stopped trading after the Rayonier merger
5 February 2026
2 mins read

PotlatchDeltic stock price today: Why PCH stopped trading after the Rayonier merger

New York, Feb 5, 2026, 15:35 ET — Regular session

  • PotlatchDeltic (PCH) shares have been suspended following the completion of its merger with Rayonier
  • The final PCH quote stood at $41.73; the deal terms convert each share into 1.8185 Rayonier shares plus $0.61 in cash
  • Rayonier shares slipped roughly 1% in afternoon trading, adjusting the implied value for former PCH shareholders

PotlatchDeltic’s shares are effectively delisted following its merger with timber REIT Rayonier, with the final PCH price recorded at $41.73, a modest 0.2% gain from the previous close. Rayonier’s stock slipped roughly 1.1% in afternoon trading, whereas fellow timber player Weyerhaeuser edged up around 0.4%.

This matters because investors holding “PCH” shares aren’t trading the company as an independent entity anymore. Instead, the value now corresponds to the stock-and-cash package they’re set to receive, which fluctuates alongside Rayonier’s share price.

This also shifts the trader’s approach. Instead of asking “where does PCH trade today?”, the question becomes about the mechanics: when do shares and cash land in brokerage accounts, and what happens to any leftover bits like fractional shares.

PotlatchDeltic announced in a filing that every share of its common stock was converted into the right to receive 1.8185 Rayonier common shares plus $0.61 in cash, with cash payments made in lieu of fractional Rayonier shares. The company also requested Nasdaq to suspend trading after the Jan. 30 after-hours session and initiate the delisting process.

Nasdaq submitted a Form 25 on Feb. 2, the SEC filing that signals a security’s removal from the exchange, targeting PotlatchDeltic common stock. According to a Nasdaq corporate actions bulletin, PCH trading was set to be suspended effective Feb. 3.

Thursday’s Rayonier price puts the merger terms at about $41.56 per former PotlatchDeltic share (1.8185 Rayonier shares plus $0.61 cash), tracking Rayonier’s drop.

Rayonier CEO Mark McHugh said, “We are excited to close this strategic merger of equals,” as the company confirmed the deal’s completion. The merged entity now controls over four million acres of timberland. It will continue using the Rayonier name and trade on the NYSE under the ticker “RYN” for the time being, with plans for a new name and ticker in the first quarter. Business Wire

Options holders face a trickier setup now. The Options Clearing Corporation announced that listed PCH options have been adjusted. The symbol will switch to a new deliverable linked to Rayonier shares plus cash. However, the cash portion’s settlement is on hold until the cash-in-lieu figure for fractional shares gets finalized.

The final payout for former PCH holders isn’t set in stone. Since most of the payment comes in Rayonier stock, any sudden shift in RYN’s price can change the implied value. Plus, delays in handing out shares or cash might leave those positions feeling “stale” long after the merger closes.

Rayonier is set to drop its fourth-quarter earnings after the closing bell on Feb. 11. Investors will get their first official look at the merged operation during the conference call the next day, Feb. 12.

Stock Market Today

  • CGI (TSX:GIB.A) Shares Seen 33% Undervalued Amid Mixed Performance
    April 29, 2026, 9:36 AM EDT. CGI's (TSX:GIB.A) stock has shown mixed returns recently, with a 1.94% gain over one month but a 14.05% decline over three months. Its current price around CA$100.64 is 33% below a fair value estimate of CA$149.62 from market analysts. This discount arises despite strong demand driven by digital transformation trends like cloud migration, AI automation, and data analytics. Investors face a balancing act between assessing CGI's growth potential and risks including client spending variability and integration challenges from acquisitions. The valuation gap highlights uncertainty whether the market undervalues this global IT services firm or preempts growth headwinds. Investors are advised to examine CGI's fundamentals and broader sector opportunities before committing capital.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court
Previous Story

JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court

Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote
Next Story

Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote

Go toTop